These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23117036)

  • 1. Membrane-perturbing effect of fatty acids and lysolipids.
    Arouri A; Mouritsen OG
    Prog Lipid Res; 2013 Jan; 52(1):130-40. PubMed ID: 23117036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fatty acids on the permeability barrier of model and biological membranes.
    Arouri A; Lauritsen KE; Nielsen HL; Mouritsen OG
    Chem Phys Lipids; 2016 Oct; 200():139-146. PubMed ID: 27725161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids, curvature stress, and the action of lipid prodrugs: free fatty acids and lysolipid enhancement of drug transport across liposomal membranes.
    Jespersen H; Andersen JH; Ditzel HJ; Mouritsen OG
    Biochimie; 2012 Jan; 94(1):2-10. PubMed ID: 21839138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of free fatty acids and lysolipids on cellular uptake of doxorubicin in human breast cancer cell lines.
    Rasmussen N; Andersen JH; Jespersen H; Mouritsen OG; Ditzel HJ
    Anticancer Drugs; 2010 Aug; 21(7):674-7. PubMed ID: 20559126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane fusion with cationic liposomes: effects of target membrane lipid composition.
    Bailey AL; Cullis PR
    Biochemistry; 1997 Feb; 36(7):1628-34. PubMed ID: 9048546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C8-glycosphingolipids preferentially insert into tumor cell membranes and promote chemotherapeutic drug uptake.
    Cordeiro Pedrosa LR; van Cappellen WA; Steurer B; Ciceri D; ten Hagen TL; Eggermont AM; Verheij M; Goñi FM; Koning GA; Contreras FX
    Biochim Biophys Acta; 2015 Aug; 1848(8):1656-70. PubMed ID: 25917957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents.
    Wagner BA; Buettner GR; Burns CP
    Cancer Res; 1992 Nov; 52(21):6045-51. PubMed ID: 1394229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceramide-induced transbilayer (flip-flop) lipid movement in membranes.
    Contreras FX; Villar AV; Alonso A; Goñi FM
    Methods Mol Biol; 2009; 462():155-65. PubMed ID: 19160667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of independent variations in fatty acid structure and chain length on lipid polar headgroup composition in Acholeplasma laidlawii B membranes: regulation of lamellar/nonlamellar phase propensity.
    Yue AW; Wong BC; Rieder J; Lewis RN; Mannock DA; McElhaney RN
    Biochemistry; 2003 Feb; 42(5):1309-17. PubMed ID: 12564934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal drug transport: a molecular perspective from molecular dynamics simulations in lipid bilayers.
    Xiang TX; Anderson BD
    Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1357-78. PubMed ID: 17092601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of membrane fatty acid remodeling in the antitumor mechanism of action of 2-hydroxyoleic acid.
    Martin ML; Barceló-Coblijn G; de Almeida RF; Noguera-Salvà MA; Terés S; Higuera M; Liebisch G; Schmitz G; Busquets X; Escribá PV
    Biochim Biophys Acta; 2013 May; 1828(5):1405-13. PubMed ID: 23360770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid-induced changes in phospholipid membranes as mediators of their action.
    Nelson DH
    Endocr Rev; 1980; 1(2):180-99. PubMed ID: 6263603
    [No Abstract]   [Full Text] [Related]  

  • 13. Bleomycin-induced trans lipid formation in cell membranes and in liposome models.
    Cort A; Ozben T; Sansone A; Barata-Vallejo S; Chatgilialoglu C; Ferreri C
    Org Biomol Chem; 2015 Jan; 13(4):1100-5. PubMed ID: 25417813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase A(2)-susceptible liposomes of anticancer double lipid-prodrugs.
    Arouri A; Mouritsen OG
    Eur J Pharm Sci; 2012 Mar; 45(4):408-20. PubMed ID: 21946258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model membrane platforms to study protein-membrane interactions.
    Sezgin E; Schwille P
    Mol Membr Biol; 2012 Aug; 29(5):144-54. PubMed ID: 22831167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural effects and lipid membrane interactions of the pH-responsive GALA peptide with fatty acid acylation.
    Lin BF; Missirlis D; Krogstad DV; Tirrell M
    Biochemistry; 2012 Jun; 51(23):4658-68. PubMed ID: 22591394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the membranes in lymphocyte interaction with mycoplasmas].
    Rakovskaia IV; Bakhramov AB; Migushina VL
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1986; (11):25-30. PubMed ID: 3028509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of some environmental factors on the content and composition of microbial membrane lipids.
    Sajbidor J
    Crit Rev Biotechnol; 1997; 17(2):87-103. PubMed ID: 9192472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of adriamycin in model and natural membranes. Influence of lipid molecular packing.
    Dupou-Cézanne L; Sautereau AM; Tocanne JF
    Eur J Biochem; 1989 May; 181(3):695-702. PubMed ID: 2731543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acids enhance membrane permeabilization by pro-apoptotic Bax.
    Epand RF; Martinou JC; Montessuit S; Epand RM
    Biochem J; 2004 Jan; 377(Pt 2):509-16. PubMed ID: 14535847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.